Display options
Share it on

Clin Case Rep. 2018 Apr 21;6(6):1109-1111. doi: 10.1002/ccr3.1499. eCollection 2018 Jun.

Congenital erythrocytosis - discover of a new mutation in the .

Clinical case reports

João Barradas, Catarina Dantas Rodrigues, Gisela Ferreira, Paula Rocha, Conceição Constanço, Maria Reis Andrade, Celeste Bento, Helena Matos Silva

Affiliations

  1. Centro Hospitalar de Tondela-Viseu EPE - Serviço de Hematologia Clínica Coimbra Portugal.
  2. Centro Hospitalar do Baixo Vouga EPE - Serviço de Hematologia Clínica Viseu Portugal.
  3. Centro Hospitalar e Universitário de Coimbra EPE - Serviço de Hematologia Clínica Coimbra Portugal.

PMID: 29881576 PMCID: PMC5986049 DOI: 10.1002/ccr3.1499

Abstract

Congenital erythrocytosis is a hereditary disorder due to an increase in red cell mass that can be caused by mutations in proteins involved in HIF-α pathway, as PHD2. Hereby, we describe a new familial mutation in PHD2 gene. Considering an increased thrombotic potential, patients began antiplatelet aggregation therapy and phlebotomies.

Keywords: Congenital erythrocytosis; hypoxia; phd2; thrombosis

References

  1. Hematology Am Soc Hematol Educ Program. 2009;:629-35 - PubMed
  2. Case Rep Hematol. 2016;2016:6373706 - PubMed
  3. Hypoxia (Auckl). 2014 Jul 01;2:71-90 - PubMed
  4. Sci Rep. 2016 Jan 12;6:18716 - PubMed
  5. Hum Mutat. 2014 Jan;35(1):15-26 - PubMed
  6. Nat Commun. 2016 Aug 26;7:12673 - PubMed
  7. Haematologica. 2008 Jul;93(7):963-7 - PubMed
  8. Haematologica. 2012 Jan;97(1):123-7 - PubMed

Publication Types